In the article titled “Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)”1 published online December 3, 2020, in JAMA Oncology, there was incorrect data presented in the Abstract and Results section regarding the number of deaths at 6 months, 6-month OS, and median OS. This article was corrected online.
Reference
- 1.Ramaswamy A, Ostwal V, Sharma A, et al. Efficacy of capecitabine plus irinotecan vs irinotecan monotherapy as second-line treatment in patients with advanced gallbladder cancer: a multicenter phase 2 randomized clinical trial (GB-SELECT). JAMA Oncol. Published online December 3, 2020. doi: 10.1001/jamaoncol.2020.6166 [DOI] [PMC free article] [PubMed] [Google Scholar]